In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics and targeted therapeutics for cancer, today announced the U.S. Patent and Trademark Office ...

In a major leap forward for genetic and biomedical research, scientists have developed a powerful new artificial intelligence tool that can predict the 3D shape of chromosomes inside individual cells ...

Miniature organs on a chip could allow us to do scientific studies with great precision, without having to resort to animal testing. The main problem, however, is that artificial tissue needs blood ...

To build their self-reproduction structures, the team began with an aqueous solution containing monomers to be polymerized, a ...

In biomedical research, so-called organs-on-a-chip, also referred to as microphysiological systems, are becoming increasingly ...

Lipid membranes, which form the outer layer of cells, can be engineered to influence cellular functions. For example, ...

Lipid membranes, which form the outer layer of cells, can be engineered to influence cellular functions. For example, adjusting the permeability of ...

This fundamental study combines in vitro reconstitution experiments and molecular dynamics simulations to elucidate how membrane lipids are transported from the outer to the inner membrane of ...

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies ...

In an AstraZeneca-developed training program, AI-assisted HER2 IHC scores had higher agreement with centrally confirmed ...